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substitute, but the pulmonary root still needs homograft
replacement.1 The frame-mounted bioprostheses,
despite changes in the fixation technique, still have lim-
ited durability.2 Furthermore, the rigid stent immobi-
lizes the host aortic anulus and sinuses and, most
important, is obstructive, especially in small sizes.3
Homograft valve durability and hemodynamic perfor-
mance are better, but availability is limited.4 To over-
come these problems there has been increasing interest
in a new generation of bioprosthesis, the stentless
porcine valve. Its availability is unlimited, the hemody-
namic characteristics are better than those of the frame-
mounted valve, and potentially the durability is longer
because of increased flexibility and reduced leaflet
deformation.5 Although the number of valves implanted
is increasing, debate continues regarding the best sizing
protocol and implantation technique, and long-term
durability still remains to be demonstrated. In an
attempt to answer some of these questions, we estab-
lished an in vitro model to investigate the effect of siz-
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the Toronto SPV valve (St Jude Medical, Inc, St Paul, Minn). Methods:
Nine valves were first implanted in fresh porcine aortic roots and then
retested in glutaraldehyde-treated porcine aortic roots. Three valves
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were 3 size-for-size implantations. The elasticities of the aortic roots and
the composite roots were measured in the pressure range between 0 and
120 mm Hg, and the composite roots were then tested in a pulsatile flow
simulator. The transvalvular gradient and regurgitation were measured
and the effective orifice area and performance index were calculated for
each root. Leaflet motion was recorded on videotape. Results: The exter-
nal diameter of the fresh root increased by 35% as the hydrostatic pres-
sure rose from 0 to 120 mm Hg, as compared with 11% for the glu-
taraldehyde-treated root. Valve implantation in the fresh root reduced
the distensibility to 22% but did not change distensibility in the glu-
taraldehyde-treated root. The effective orifice area was dependent on
the valve size, with the transvalvular gradient decreasing as the valve
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were slightly better if the valve was undersized by 1 mm. A significant
difference in favor of the undersized valves was found in open-leaflet
bending deformation. Conclusion: Leaflet motion of the stentless porcine
aortic valve in vitro is improved if the valve is slightly undersized, and
this may be beneficial to the long-term durability of the prosthesis. (J
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ing on the hydrodynamic characteristics and leaflet
deformation of the Toronto SPV stentless bioprosthesis
(St Jude Medical, Inc, St Paul, Minn).
Materials and methods
Three 19-mm, three 21-mm, and three 23-mm standard
Toronto SPV valves were tested in our series. The valves
were implanted in fresh porcine aortic roots and glutaralde-
hyde-treated porcine aortic roots. These 2 types of root were
selected because they represent the extremes of the compli-
ance range, as recommended by the Food and Drug
Administration for valve testing.
Aortic roots. Aortic roots were dissected out from fresh
pig hearts, stored at 4°C in normal saline solution, and used
within 24 hours or fixed in 0.5% glutaraldehyde solution for
48 hours. The right and left coronary arteries were ligated.
The annular size was measured by passing an obturator
through the anulus from the ventricular side. The external
diameters of the aortic roots were measured at the sinotubu-
lar junction at hydrostatic pressures of 0, 60, 80, 100, and 120
mm Hg by means of digital vernier calipers.
Technique of valve insertion. The lower rim of the valve
was sewn to the host anulus with 4-0 continuous polypropy-
lene suture from the ventricular side in such a way that the
valve was sitting on the anulus. A 5-0 polypropylene com-
missural suspending mattress suture was placed at the top of
each commissure, passing through the host aortic wall in
alignment with the host’s commissural attachment. The upper
row of subcoronary continuous sutures was placed through
the scalloped upper margin of the valve and through the half-
thickness of the host aortic wall with 5-0 polypropylene
suture in such a way that the coronary ostia remained clear.
Then the external diameters of the composite roots were mea-
sured at the sinotubular junction at hydrostatic pressures of 0,
60, 80, 100, and 120 mm Hg.
Hydrodynamic testing. The composite roots were tested
in a pulsatile flow simulator, details of which have been
described previously elsewhere.6 The flow simulator consist-
ed of 2 rigid cylindric test sections for each of the mitral and
aortic valves, a compliance chamber, peripheral resistance,
and an atrial reservoir. The system was driven by a servo-con-
trolled piston pump. The composite roots were mounted in
place of the rigid aortic valve section (Fig 1) and tested at a
rate of 72 cycles/min with a stroke volume of 70 mL for a sys-
temic pressure of 120/80 mm Hg. The pressure difference
across the root was measured directly by a differential trans-
ducer, and the flow was measured with an electromagnetic
flowmeter positioned downstream from the valve. Pressure,
flow, pump displacement, and velocity signals were collected
digitally for 10 seconds at a sampling frequency of 200 Hz
and stored on disk for analysis with an IBM PS/2 computer
(International Business Machines Corp, White Plains, NY).
The data were ensemble averaged to create 1 cycle, and
valve function was analyzed with respect to this averaged
waveform. The effective orifice area (EOA) was calculated
according to the following formula: EOA = Q/51.6 · √D p
(where Q is the root mean square forward flow in milliliters
per second and D p is the mean pressure drop during forward
flow in millimeters of mercury). The performance index (PI)
of the valve was derived from the following formula: PI =
EOA/Theoretic orifice area (where the theoretic orifice area
was p r2, with r the radius of the valve anulus). Valve leaflet
movements were recorded with a video camera positioned
axially to the flow through the aorta to determine the config-
uration of the open valve leaflets. A spigot of the same diam-
eter as that of the aorta in its distended state allowed a video
recording of the leaflet motions of the entire valve, including
the commissural area. The open-leaflet bending deformations
were determined from the still image of the fully open posi-
tion in midsystole by means of an image-analysis system.
The open-leaflet deformation at the commissures was quanti-
fied by taking 3 points along the leaflet edge in the region of
maximum deformation (Fig 2). The spatial deviation of the
center point (BD) from the straight line formed by joining the
2 endpoints (AC) was used as a measure of leaflet deforma-
tion.7 The ratio BD/BC was used as a leaflet-bending defor-
mation index (BDI). The BDI was quantified at all 3 com-
missures, and the average of these data was given as a
characteristic of the valve. The mean and standard deviation
of the data were calculated. Statistical analysis was per-
formed by Student t test.
Results
The distensibilities of the roots are shown in Fig 3.
The fresh aortic roots were extremely elastic, with the
external diameters of the roots at the sinotubular junc-
tion dilating 35% ± 7.8% as the pressure increased
from 0 to 120 mm Hg. In the physiologic range
between 80 and 120 mm Hg, there was a 10% ± 3.5%
change in external diameter. After implantation of the
Toronto SPV valve the elasticity decreased significantly;
Fig 1. Porcine aortic root mounted in the aortic valve section
of the pulsatile flow simulator, attached to appropriately sized
inflow and outflow spigots.
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the dilatation from 0 to 120 mm Hg was only 22% ±
3.9%, and in the physiologic range it dropped to 5% ±
1.7% (P = .0001). Glutaraldehyde treatment made the
native roots a lot stiffer. We found only a change of
11% ± 2.8% in external diameter between 0 and 120
mm Hg pressures. Valve implantation did not reduce
the distensibility of the glutaraldehyde-treated roots
significantly (P = .2).
Fig 2. The fold in the leaflet (ABC) was converted into a triangle to quantify the bending in the leaflet. If BD/BC
was closer to zero, the leaflet was said to be more in a straight line, whereas if it was nearing 1, the folding was
considered greater.
Fig 3. The mean percentages of dilatation for native aortic root, glutaraldehyde-treated aortic root, native com-
posite root, and glutaraldehyde-treated composite root in the pressure range between 0 and 120 mm Hg.
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The transvalvular gradients measured for the com-
posite roots are listed in Table I. Obviously, the bigger
valves had lower gradients in both groups. The gradi-
ents measured for the glutaraldehyde-treated composite
roots were slightly greater than for the fresh composite
roots, but the difference was significant only for the 19-
mm valves (P = .002). For each valve size the mea-
surements showed a slightly smaller gradient when the
valve was undersized, but a major difference was found
only when the valve was severely oversized or under-
sized (Table I).
Table II shows the calculated EOAs for the 2 groups
of composite roots. Again, the bigger valves had larger
orifice areas in both groups. It was also demonstrated
that the EOA was slightly bigger in the case of under-
sized valves. The orifice area was significantly less for
the glutaraldehyde-treated composite roots only at the
19-mm valve size (P = .01).
The closing volumes were similar in all valves.
Regurgitation was detected only in 1 valve, which was
undersized by more than 2 mm. This valve had a cen-
tral coaptation defect in the diastolic phase as a result
of overstretching of the valve leaflets (Fig 4). All the
other valves were competent.
Table III summarizes the PIs and the BDIs of the
implanted stentless valves. The sizing protocol did not
have any effect on the PI for either the fresh or the glu-
taraldehyde-treated roots, but the PI was significantly
higher in the fresh composite roots than in the glu-
taraldehyde-treated roots (P = .03). A significant differ-
ence between the oversized and undersized valves was
also found in the BDI; this difference was in favor of
undersizing (P = .009 for the fresh roots, P = .007 for
the glutaraldehyde-treated roots). The 2-mm oversized
valve in a fresh root produced a BDI of 0.55 (Fig 5).
The BDI of the 1-mm oversized valves averaged 0.35 ±
0.02 (Fig 6), whereas the 1-mm undersized valves
showed the best BDI of 0.17 ± 0.01 and the valves still
remained competent (Fig 7). The glutaraldehyde-treat-
ed group showed a similar trend.
Discussion
The first heterologous aortic valve implantations
were performed in 1964 by Binet and Duran.8 The
early results were promising in terms of hemodynamic
performance, but inadequate tissue preservation
allowed early structural deterioration. The durability of
bioprosthetic valves was much improved with the
introduction of glutaraldehyde tissue preservation.9
Table I. Transvalvular gradients measured for Toronto
SPV valves implanted in different sizes of fresh and
glutaraldehyde-treated porcine aortic roots
Glutaraldehyde-
Fresh treated P*
19 mm .002
Oversized 7.4 11.5
Size for size 7.1 11.9
Undersized 6.2 10.1
21 mm .20
Oversized 4.7 5.9
Size for size 5.0 5.7
Undersized 3.4 3.9
23 mm .50
Oversized 7.6† 5.5
Size for size 2.6 3.9
Undersized 1.8‡ 2.6
All gradient values are in millimeters of mercury.
*By t test.
†Valve oversized by 2 mm.
‡Valve undersized by more than 2 mm.
Table II. EOAs calculated for Toronto SPV valves im-
planted in different sizes of fresh and glutaraldehyde-
treated porcine aortic roots
Glutaraldehyde-
Fresh treated P*
19 mm .01
Oversized 1.77 1.44
Size for size 1.83 1.54
Undersized 1.97 1.66
21 mm .20
Oversized 2.22 2.01
Size for size 2.20 2.06
Undersized 2.66 2.47
23 mm .40
Oversized 1.66† 2.11
Size for size 2.97 2.49
Undersized 3.24‡ 2.85
All EOA values are in square centimeters.
*By t test.
†Valve oversized by 2 mm.
‡Valve undersized by more than 2 mm.
Table III. PIs and BDIs of the Toronto SPV valves im-
planted in different sizes of fresh and glutaraldehyde-
treated porcine aortic roots
Glutaraldehyde-
Fresh treated P*
PI .03
Oversized 60 ± 11.6 59 ± 4.4
Size for size 66 ± 3.8 58 ± 3.5
Undersized 66 ± 3.5 60 ± 6.4
BDI .20
Oversized 0.41 ± 0.10 0.44 ± 0.06
Size for size 0.26 ± 0.07 0.36 ± 0.09
Undersized 0.14 ± 0.06 0.27 ± 0.04
*By t test.
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Because of the favorable midterm results and easy
implantation technique, the frame-mounted porcine
valve became the bioprosthesis of choice in most car-
diac centers in the 1970s and 1980s. As time passed,
however, it became clear that long-term results were
not ideal. Late structural deterioration has been attrib-
uted to the bending strains at the commissures caused
by the rigid frame. To overcome this problem a new
generation of bioprosthesis, the glutaraldehyde-fixed
stentless porcine valve, was developed. In 1990 David
and coworkers10 reported superior hemodynamic
results in 22 freehand-implanted stentless xenografts
compared with the same number of frame-mounted
xenografts. Theoretically, if the durability of the valve
depends on leaflet deformation and bending strains,
stentless valves should last longer than the stented
valves. In this in vitro study we investigated whether
the sizing of the valve has any effect on the hemody-
namic performance and the leaflet deformation.
The porcine aortic roots, which were comparable in
size to the human aorta, were harvested from piglets.
Two major differences from the human aorta were
found: the porcine aortic wall was a lot thicker, and
also probably much more elastic, than elderly human
calcified aortic anulus and root would be. In an
attempt to reduce elasticity, a second set of porcine
roots was treated with glutaraldehyde. This made the
aortic wall even thicker, rubbery and stiff, which again
did not show great similarity to human tissues.
Implanting the valves in these 2 types of roots provid-
Fig 6. Toronto SPV valve oversized by 1 mm in its fully
opened position.
Fig 7. Toronto SPV valve undersized by 1 mm. This valve
showed minimal leaflet deformation in its fully opened posi-
tion and was still competent.
Fig 4. Toronto SPV valve undersized by more than 2 mm.
The overstretched leaflets were unable to close in diastole.
Fig 5. Toronto SPV valve oversized by 2 mm. There was lot
of leaflet deformation in its fully open position.
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ed a range of compliances, however, as recommended
by the Food and Drug Administration for testing free-
sewn valves. Implanting a Toronto SPV valve into a
fresh aortic root reduced the root’s distensibility sig-
nificantly. Our previous study showed that suturing
fresh or glutaraldehyde-treated scalloped aortic valves
into fresh aortic roots did not change the distensibility
of the host root.11 It is probable that the thin polyeth-
ylene terephthalate (Dacron) cloth that covered the
muscle shelf and the commissures was responsible for
the reduced elasticity. These types of observations are
only possible when using a tissue host root model and
correct surgical procedure for in vitro testing of free-
sewn valves.
Our results support the previous findings of other
investigators that the hemodynamic performance of the
stentless valves is better than that of the frame-mount-
ed valves, especially in small sizes.10,12-14 The size of
the host aortic root was measured at the level of the
anulus. Most of the aortic roots’ internal diameters
were 1 to 2 mm larger at the sinotubular junction than
at the anulus. Furthermore, the aortic wall at the sino-
tubular junction was more distensible than the fibrous
anulus, and this plays an important role in normal aor-
tic valve function.15 We found it easier and more accu-
rate to size the root at the anulus than at the sinotubular
junction. Oversizing by 1 to 2 mm according to the
anulus diameter was thus equivalent to size-for-size
implantation at the sinotubular junction. The current
recommendation for sizing stentless valves is that if the
sinotubular junction diameter is larger than the anulus,
then the larger size is used as the valve size to avoid
regurgitation, as long as it is not different by more than
2 sizes. Our measurements did not show regurgitation
on the undersized valves, however, even if they were
implanted in extremely elastic fresh aortic roots. The
single valve that was incompetent was implanted in a
fresh aortic root with an internal diameter that was
more than 2 mm bigger than the valve size. That par-
ticular root’s internal diameter was a lot bigger at the
sinotubular junction than at the anulus. On testing we
found very little open leaflet bending deformation and
nearly normal triangular orifice (Fig 8), but the over-
stretched leaflets were unable to close in diastole (Fig
4). On the other hand, in both groups we found a slightly
larger orifice area and lower transvalvular gradient on
the Toronto SPV valve if it was undersized by 1 mm
than in the case of either size-for-size implantation or
oversizing, although the differences were not signifi-
cant. Most important, the sizing had a marked effect on
the open-leaflet bending deformation. In both groups
the BDI was significantly lower when the valve was 1-
mm undersized on the anulus than if the matching size
valve or an oversized valve was used.
Our in vitro measurements suggest that, in small aor-
tic roots, 1-mm undersizing of the stentless valve
results in better hemodynamic performance without the
hazard of regurgitation. The reduced open-leaflet bend-
ing deformation may have an important effect on long-
term durability. In dilated aortic roots with great dis-
crepancy between the size of the sinotubular junction
and the anulus (eg, poststenotic dilatation), however,
the implantation of a stentless bioprosthesis is not
recommended.16
Conclusion. In our series we found slightly better
hemodynamic performance and significantly less open-
leaflet bending deformation for the Toronto SPV stent-
less valve when it was implanted in a 1-mm larger fresh
or glutaraldehyde-treated porcine aortic root. In those
roots in which the internal diameters of the aortic root
were similar at the anulus and at the sinotubular junc-
tion, the valve undersizing did not result in regurgita-
tion. Moreover the reduced open-leaflet bending defor-
mation could be an important determinant of long-term
durability.
We thank Devon Darby and John Moore for their kind tech-
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